Login

Dr Anil Diwan, CEO, NanoViricides Inc 00:00:00

Share On Facebook Share On Twitter

NanoViricides announces key data on Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Creating impact at scale for the worlds largest and most influential corporations|Brendan Wallace,Managing Partner,Fifth Wall
00:10:00
Grateful for Keystone Global Network's Support in My Canadian Visa Process
00:10:00
Personalized Team-Based Financial Guidance for Your Success
00:10:00
Navitas Semiconductor CEO Gene Sheridan discusses the company's Q2 results, business challenges, and future prospects on 'Power Lunch'.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
Meet Ioannis, Senior Account Manager at NCAB Group, in this interview featuring PCB specialists from around the world.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
StrikePoint Gold Gears Up for Drilling at Hercules Project in Nevada|Michael G. Allen,CEO,StrikePoint Gold Inc
00:10:00
Unveiling the Unseen: Exploring Ground-Penetrating Radar in Art and Education
00:10:00
Financial Venture model is little bit different|Tyler Griffin,Managing Partner,Restive Ventures
00:10:00
Danimer CEO Unveils Nature-Inspired Biodegradable Plastic Innovation | Stephen E. Croskrey - CEO of Danimer Scientific
00:10:00
Sachin Khajuria’s Private Equity Playbook
00:00:00
BioPorto discusses 'fantastic first half of the year' driven by antibodies and RUO NGAL Test sales - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:10:00
Understanding Your FICO Score: Finance Moment Podcast | Jerin Young - Senior Associate Financial Planner of Syverson Strege

© 2017 - Neuhu+